Dr. Mehmet Oz Praises Trump for Lowering Drug Costs

On October 3, 2025, Dr. Mehmet Oz spoke during an interview with Newsmax and praised former President Donald Trump for his actions to reduce the high cost of prescription drugs in the United States. Oz said Trump was able to take on the powerful pharmaceutical lobby because he was “undaunted” by its influence. According to him, Trump’s willingness to fight against one of the strongest industries in Washington was a rare quality in politics and allowed him to deliver results for patients and families.

Oz explained that for decades the rising cost of prescription drugs has placed a heavy financial burden on millions of Americans. Families across the country have been forced to make difficult choices between paying for medicines or covering other basic needs. While many politicians have promised to bring down prices, the pharmaceutical lobby has remained a powerful obstacle. Oz pointed out that Trump was different because he was willing to challenge these interests directly, despite the risks and political pressure.

During his presidency, Trump introduced policies that aimed to open the market to more affordable options. His administration supported the entry of generic drugs and worked to create more competition among pharmaceutical companies. These steps were designed to break monopolies and prevent companies from keeping prices artificially high. While the industry pushed back strongly, Oz said Trump’s refusal to retreat showed his determination to make health care more affordable for ordinary Americans.

Oz also stressed that Trump’s approach highlighted how leadership can make a difference in tackling long-standing problems. He said that being willing to stand firm against special interest groups is rare in Washington, yet it is essential if policies are going to put people before corporate profits. Trump’s actions, according to Oz, set an example of how persistence and courage can bring real change in health care policy.

The rising price of prescription medicine continues to be one of the most pressing issues in the country. Many families are still struggling to pay for treatments, and the debate over how to lower costs is expected to play a central role in upcoming elections. Oz’s comments underline the importance of this issue and suggest that drug affordability will remain a top concern for voters in 2026 and beyond.

For Oz, the main lesson is clear: progress is possible when leaders are willing to stand up to powerful industries and refuse to be intimidated. Trump’s record, he argued, shows that determination and bold action can deliver meaningful results for Americans who depend on life-saving medications.